A revolutionary new treatment discovered by researchers at Stanford University may may reduce the effects of peanut allergy to normal levels for several weeks at a time with just an injection.
The injection, known as “Etokimab” does not target any of the actual allergens associated with peanuts but rather that mechanism of reaction itself, notably the cascade of allergic reactions which happen afterward.
Because of this, the treatment may work for all food allergies which affect 32 million Americans every year. Peanut allergies alone affect 1.2 million Americans. There are over 200,000 Emergency Room visits every year due to severe reactions to food allergies.
The study divided people into two groups, both with peanut allergies. In one group, they were given the Etokimab and the other group was given a placebo. The placebo group showed zero improvement but 72% of the Etokimab group were able to ingest a little peanut protein without severe reactions.
Currently, the drug is still being tested so it may be a few years before it can be released. Doctors involved in the research pointed out that, although the efficacy of the drug is being demonstrated, there are many details to work out such as dose schedules and administration.
Source: Yahoo! News